These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27542739)

  • 1. Trivalent metal ions based on inorganic compounds with in vitro inhibitory activity of matrix metalloproteinase 13.
    Wen H; Qin Y; Zhong W; Li C; Liu X; Shen Y
    Enzyme Microb Technol; 2016 Oct; 92():9-17. PubMed ID: 27542739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting effects of common trivalent metal ions on transmembrane-type 2 matrix metalloproteinase.
    Ren L; Yu D; Wang Y; Shen L; Zhang J; Wang Y; Fang X
    Int J Biol Macromol; 2018 Nov; 119():683-691. PubMed ID: 30048727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.
    Fischer T; Riedl R
    Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Production of Catalytic Domains of Human MMPs in Escherichia coli Periplasm.
    Nam DH; Lee KB; Ge X
    Methods Mol Biol; 2018; 1731():65-72. PubMed ID: 29318544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.
    Choi JY; Fuerst R; Knapinska AM; Taylor AB; Smith L; Cao X; Hart PJ; Fields GB; Roush WR
    J Med Chem; 2017 Jul; 60(13):5816-5825. PubMed ID: 28653849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor.
    Senn N; Ott M; Lanz J; Riedl R
    J Med Chem; 2017 Dec; 60(23):9585-9598. PubMed ID: 28953404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry.
    Parker MH; Lunney EA; Ortwine DF; Pavlovsky AG; Humblet C; Brouillette CG
    Biochemistry; 1999 Oct; 38(41):13592-601. PubMed ID: 10521266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics.
    Edkins TJ; Alhadeff JA; Kwok V; Kalensky C; Rock MT; Vidmar TJ; Del Tito BJ
    J Pharm Biomed Anal; 2012 Nov; 70():408-14. PubMed ID: 22854133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.
    Choi JY; Fuerst R
    Methods Mol Biol; 2017; 1579():259-271. PubMed ID: 28299742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
    Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
    Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
    J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.
    Ramezani M; Shamsara J
    Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.
    Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM
    J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of silver diamine fluoride at different concentrations on matrix metalloproteinases.
    Mei ML; Li QL; Chu CH; Yiu CK; Lo EC
    Dent Mater; 2012 Aug; 28(8):903-8. PubMed ID: 22578660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
    Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A
    J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.
    Schröder J; Henke A; Wenzel H; Brandstetter H; Stammler HG; Stammler A; Pfeiffer WD; Tschesche H
    J Med Chem; 2001 Sep; 44(20):3231-43. PubMed ID: 11563922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.